archetype (adl_version=1.4; uid=adc6c335-bec2-416d-b088-457e7b1b6249) openEHR-EHR-OBSERVATION.damico_risk_classification_prostate_cancer.v0 concept [at0000] -- D'Amico risikoklassifisering prostatakreft language original_language = <[ISO_639-1::nb]> translations = < ["en"] = < language = <[ISO_639-1::en]> author = < ["name"] = <"Bjørn Næss"> ["organisation"] = <"DIPS AS"> ["email"] = <"bna@dips.no"> > > > description original_author = < ["name"] = <"Bjørn Næss"> ["organisation"] = <"DIPS AS"> ["email"] = <"bna@dips.no"> ["date"] = <"2022-03-01"> > details = < ["nb"] = < language = <[ISO_639-1::nb]> purpose = <"Skåringen vurderer 5 års risiko for behandlingssvikt basert på kliniske faktorer. For å estimere kontroll av prostataspesifikt antigen (PSA) etter radikal prostatektomi (RP), ekstern strålestråling (RT), eller implantat med eller uten neoadjuvant androgen deprivasjonsterapi hos pasienter med klinisk lokalisert prostatakreft."> use = <"D'Amico ble utviklet i 1998 og estimerer risikoen for tilbakefall av prostatakreft (lav, middels eller høy) fra PSA-nivå, ISUP Grade Group og tumorstadium. Den kan imidlertid være mindre nøyaktig hos menn med flere risikofaktorer. Lav risiko: ISUP Grade Group 1 og PSA < 10 ug/L og Klinisk stadium T1c eller T2a Middels risiko: ISUP Grade Group 2 eller 3, eller PSA 10-20 ug/L eller Klinisk stadium T2b Høy risiko: ISUP Grade Group 4 eller 5, eller PSA > 20 ug/L eller Klinisk stadium T2c eller T3"> misuse = <""> copyright = <"© Nasjonal IKT HF"> > ["en"] = < language = <[ISO_639-1::en]> purpose = <"The score assesses the 5-year risk of treatment failure based on clinical factors. To estimate control of prostate-specific antigen (PSA) after radical prostatectomy (RP), external beam radiation (RT), or implant with or without neoadjuvant androgen deprivation therapy in patients with clinically localized prostate cancer."> use = <"D'Amico was developed in 1998 and estimates the risk of recurrence of prostate cancer (low, medium or high) from PSA level, ISUP Grade Group and tumor stage. However, it may be less accurate in men with multiple risk factors. Low risk: ISUP Grade Group 1 and PSA <10 ug / L and Clinical stage T1c or T2a Medium risk: ISUP Grade Group 2 or 3, or PSA 10-20 ug / L or Clinical stage T2b High risk: ISUP Grade Group 4 or 5, or PSA> 20 ug / L or Clinical stage T2c or T3"> misuse = <""> copyright = <"© Nasjonal IKT HF"> > > lifecycle_state = <"in_development"> other_contributors = <"Martine Louise Nalum ", ...> other_details = < ["licence"] = <"This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/."> ["custodian_organisation"] = <"Nasjonal IKT"> ["references"] = <"Anthony V. D'Amico, MD, PhD; Richard Whittington, MD; S. Bruce Malkowicz, MD; et al JAMA. 1998;280(11):969-974. doi:10.1001/jama.280.11.969"> ["original_namespace"] = <"no.nasjonalikt"> ["original_publisher"] = <"Nasjonal IKT"> ["custodian_namespace"] = <"no.nasjonalikt"> ["MD5-CAM-1.0.1"] = <"C76551EFA2B9ABBFC9CC3407FB51FB59"> ["build_uid"] = <"b7ca4a5b-014d-43ad-95bc-671b96a1c607"> ["revision"] = <"0.0.1-alpha"> > definition OBSERVATION[at0000] matches { -- D Amico risikoklassifisering prostatakreft data matches { HISTORY[at0001] matches { -- Event Series events cardinality matches {1..*; unordered} matches { EVENT[at0002] occurrences matches {0..1} matches { -- Any event data matches { ITEM_TREE[at0003] matches { -- Tree items cardinality matches {0..*; unordered} matches { ELEMENT[at0004] occurrences matches {0..1} matches { -- PSA-nivå value matches { DV_CODED_TEXT matches { defining_code matches { [local:: at0021, -- <10 ug/L at0022, -- 10-20 ug/L at0023] -- >20 ug/L } } } } ELEMENT[at0005] occurrences matches {0..1} matches { -- ISUP Grade Group value matches { DV_CODED_TEXT matches { defining_code matches { [local:: at0018, -- ISUP 1 at0019, -- ISUP 2 eller 3 at0020] -- ISUP 4 eller 5 } } } } ELEMENT[at0006] occurrences matches {0..1} matches { -- Klinisk stadium value matches { DV_CODED_TEXT matches { defining_code matches { [local:: at0015, -- T1-T2a at0016, -- T2b at0017] -- ≥T2c } } } } ELEMENT[at0008] occurrences matches {0..1} matches { -- Risikoklassifisering value matches { DV_CODED_TEXT matches { defining_code matches { [local:: at0012, -- Lav risiko at0013, -- Middels risiko at0014] -- Høy risiko } } } } ELEMENT[at0007] occurrences matches {0..1} matches { -- Kommentar value matches { DV_CODED_TEXT matches {*} } } } } } } } } } } ontology term_definitions = < ["nb"] = < items = < ["at0000"] = < text = <"D'Amico risikoklassifisering prostatakreft"> description = <"D'Amico risikoklassifisering for prostatakreft vurderer 5 års risiko for behandlingssvikt basert på kliniske faktorer."> > ["at0001"] = < text = <"Event Series"> description = <"@ internal @"> > ["at0002"] = < text = <"Any event"> description = <"*"> > ["at0003"] = < text = <"Tree"> description = <"@ internal @"> > ["at0004"] = < text = <"PSA-nivå"> description = <"*"> > ["at0005"] = < text = <"ISUP Grade Group"> description = <"*"> > ["at0006"] = < text = <"Klinisk stadium"> description = <"*"> > ["at0007"] = < text = <"Kommentar"> description = <"*"> > ["at0008"] = < text = <"Risikoklassifisering"> description = <"*"> > ["at0012"] = < text = <"Lav risiko"> description = <"Gleason skår <6 og PSA <10 ug/L og klinisk stadium T1c eller T2a"> > ["at0013"] = < text = <"Middels risiko"> description = <"Gleason skår 7 eller PSA 10-20 ug/L eller klinisk stadium T2b"> > ["at0014"] = < text = <"Høy risiko"> description = <"Gleason skår >8 eller PSA >20 ug/L eller klinisk stadium T2c eller T3"> > ["at0015"] = < text = <"T1-T2a"> description = <"*"> > ["at0016"] = < text = <"T2b"> description = <"*"> > ["at0017"] = < text = <"≥T2c"> description = <"*"> > ["at0018"] = < text = <"ISUP 1"> description = <"Tilsvarer Gleason skår ≤6."> > ["at0019"] = < text = <"ISUP 2 eller 3"> description = <"Tilsvarer Gleason skår 7 (3 + 4) eller 7 (4 + 3)."> > ["at0020"] = < text = <"ISUP 4 eller 5"> description = <"Tilsvarer Gleason skår 8 eller 9-10."> > ["at0021"] = < text = <"<10 µg/L"> description = <"*"> > ["at0022"] = < text = <"10-20 µg/L"> description = <"*"> > ["at0023"] = < text = <">20 µg/L"> description = <"*"> > > > ["en"] = < items = < ["at0000"] = < text = <"D'Amico risk classification for prostate cancer"> description = <"D'Amico risk classification for prostate cancer assesses 5 years risk of treatment failure based on clinical factors."> > ["at0001"] = < text = <"Event Series"> description = <"@ internal @"> > ["at0002"] = < text = <"Any event"> description = <"*"> > ["at0003"] = < text = <"Tree"> description = <"@ internal @"> > ["at0004"] = < text = <"PSA Level"> description = <"*"> > ["at0005"] = < text = <"ISUP Grade Group"> description = <"*"> > ["at0006"] = < text = <"Clinical stage"> description = <"*"> > ["at0007"] = < text = <"Comment"> description = <"*"> > ["at0008"] = < text = <"Risk classification"> description = <"*"> > ["at0012"] = < text = <"Low risk"> description = <"Gleason score <6 and PSA <10 ug / L and clinical stage T1c or T2a"> > ["at0013"] = < text = <"Intermediate risk"> description = <"Gleason score 7 or PSA 10-20 ug / L or clinical stage T2b"> > ["at0014"] = < text = <"High risk"> description = <"Gleason score> 8 or PSA> 20 ug / L or clinical stage T2c or T3"> > ["at0015"] = < text = <"T1-T2a"> description = <"*"> > ["at0016"] = < text = <"T2b"> description = <"*"> > ["at0017"] = < text = <"≥T2c"> description = <"*"> > ["at0018"] = < text = <"ISUP 1"> description = <"Equivalent to Gleason score ≤6."> > ["at0019"] = < text = <"ISUP 2 eller 3"> description = <"Equivalent to Gleason score 7 (3 + 4) or 7 (4 + 3)."> > ["at0020"] = < text = <"ISUP 4 eller 5"> description = <"Equivalent to Gleason score 8 or 9-10."> > ["at0021"] = < text = <"<10 ug/L"> description = <"*"> > ["at0022"] = < text = <"10-20 ug/L"> description = <"*"> > ["at0023"] = < text = <">20 ug/L"> description = <"*"> > > > >